Hospice News July 25, 2024
Amedisys Inc. (NASDAQ: AMED) saw hospice revenue and census growth as it awaits the final determination of its pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum.
The company’s hospice segment earned $204 million during Q2 2024, up from $199.2 million year over year. Amedisys also saw a 0.4% increase in same-store average daily census (ADC). Hospice ADC reached 12,968 patients during Q2, up from 12,916 in the prior year’s period.
Hospice admissions, however, declined to 12,124 in the second quarter of the year, down from 12,395 in Q2 2023. Gross margin for the hospice segment also fell slightly to 49% from 50.6% year-over-year.
“Cost per day up $4.47 (+5.3%) primarily due to raises, wage inflation, an increase in...
Today's Sponsors
Today's Sponsor